Proteo Inc Revenue Growth Rates (PTEO), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Proteo Inc  (PTEO)
 

PTEO's Revenue Growth by Quarter and Year

Proteo Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PTEO Revenue (in millions $) FY 2020 FY 2019 FY 2018 FY 2017
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.00
FY 0.00

PTEOs Annual Revenue
Proteo Inc's Revenue in the fiscal year 2019 $ 0.00 millions
Proteo Inc's Revenue in the fiscal year 2018 $ 0.21 millions
Proteo Inc's Revenue in the fiscal year 2017 $ 0.20 millions
Proteo Inc's Revenue in the fiscal year 2016 $ 0.24 millions
Proteo Inc's Revenue in the fiscal year 2015 $ 0.83 millions




PTEO Revenue first quarter 2020 Y/Y Growth Comment
Proteo Inc in the first quarter 2020 achieved Revenue of $ 0.00 millions compare to recorded in same quarter a year ago.

According to the results reported in the first quarter 2020, Proteo Inc achieved the best Revenue growth in Major Pharmaceutical Preparations industry. While Proteo Inc' s Revenue no change of 0% ranks overall at the positon no. in the first quarter 2020.


PTEO Revenue ( Y/Y Growth %) 2020
 2019 2018 2017
4th Quarter December - - - 20 %
3rd Quarter September - - -60 % -54.55 %
2nd Quarter June - - -33.33 % 50 %
1st Quarter March - - 350 % 0 %
FY   - - 9.52 % -

Financial Statements
Proteo Inc's first quarter 2020 Revenue $ 0.00 millions PTEO's Income Statement
Proteo Inc's first quarter 2019 Revenue $ 0.00 millions Quarterly PTEO's Income Statement


PTEO Revenue (Quarter on Quarter Growth %)

 2020
 2019 2018 2017
4th Quarter December - - - 20 %
3rd Quarter September - - -50 % -16.67 %
2nd Quarter June - - -77.78 % 50 %
1st Quarter March - - 200 % -20 %
FY (Year on Year)   - - 9.52 % -


Back to PTEO Growth rate Comparisons >> Back to PTEO Growth rate Comparisons >>


Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2020 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2017, 2018, 2019, 2020

Proteo Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTEO's I. Quarter Q/Q Revenue Comment


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


PTEO's I. Quarter Q/Q Revenue Comment


Proteo Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2020)		 12 Months Ending
(Dec 31 2019)		 12 Months Ending
(Sep 30 2019)		 12 Months Ending
(Jun 30 2019)		 12 Months Ending
(Mar 31 2019)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Mar 31 2020 period, Proteo Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Proteo Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Mar 31 2020 period, Proteo Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Proteo Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PTEO's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Mar 31 2020 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2020
Regenerx Biopharmaceuticals inc -0.01%$ -0.005 millions
Seaspine Holdings Corporation-0.11%$ -0.108 millions
Bausch Health Companies Inc -0.20%$ -0.198 millions
Abiomed Inc -0.20%$ -0.204 millions
Lite Strategy Inc -0.40%$ -0.400 millions
Tenet Healthcare Corp-0.55%$ -0.550 millions
Pediatrix Medical Group Inc -0.62%$ -0.619 millions
Icu Medical Inc-0.70%$ -0.703 millions
Neos Therapeutics Inc -0.96%$ -0.964 millions
Hanger inc.-1.13%$ -1.134 millions
Atricure Inc -1.37%$ -1.373 millions
Integra Lifesciences Holdings Corp-1.49%$ -1.492 millions
United Therapeutics Corporation-1.74%$ -1.737 millions
Inogen Inc -1.90%$ -1.899 millions
Conmed Corporation-2.00%$ -2.000 millions
Invacare Holdings Corporation-2.23%$ -2.229 millions
Lifeloc Technologies Inc -2.44%$ -2.437 millions
Allied Healthcare Products inc -2.63%$ -2.631 millions
Fuse Medical Inc -2.81%$ -2.812 millions
U S Physical Therapy Inc-3.02%$ -3.023 millions
Icad Inc-3.19%$ -3.189 millions
Integrated Biopharma Inc-3.24%$ -3.244 millions
Livanova Plc-3.35%$ -3.351 millions
Cardiovascular Systems Inc -3.37%$ -3.374 millions
Sientra Inc -3.53%$ -3.532 millions
Accuray Incorporated-3.56%$ -3.558 millions
Quest Diagnostics Inc-3.65%$ -3.649 millions
Harrow Inc -3.85%$ -3.849 millions
Fonar Corporation-3.89%$ -3.891 millions
Nanostring Technologies Inc -3.91%$ -3.911 millions


About Proteo Inc Revenue Growth Rates (PTEO), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.